MMizuho OOracle · ORCL

Mizuho Reiterates Outperform Rating on Oracle

Jun 15, 2026· 1 min read· Reproduced verbatim
Rating
Buy
Price target
$320
Previous
Implied upside
+74%

Mizuho analyst Siti Panigrahi reiterated an Outperform rating and $320.00 price target on Oracle (NYSE: ORCL).

“Oracle delivered a strong FQ4, with IaaS accelerating to 90%+ Y/Y as the Abilene supercluster and new capacity came online on schedule.

More importantly, the quarter addressed the two debates weighing on shares.

Oracle disclosed FY27 gross CapEx of $90-95B, netting to ~$70B cash outlays, and confirmed incremental financing needs of $20B (after $50B discussed in FQ3), with total well below the $100B Street estimates management dismissed at FQ2.

With 1GW of capacity expected online in FQ1 alone, matching all of FY26, we view the FY27 revenue guide as a conservative starting point.

While management confirmed FY27 and FY28 as the peak CapEx years, the BYOC/prepayment model should help get Oracle to a point where it self-funds its growth and the financing overhang fades and investor focus shifts to FCF inflection.

With shares down 10% post-FQ4, we view this as a buying opportunity. Reiterate Outperform rating, $320 PT.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.